New Anti-Malarial Medicine Treats Toxoplasmosis
Posted on April 19, 2008
A new Anti-Malarial drug that will be entering clinical trials for treating malaria also appears to be 10 times more effective than current medical treatments for toxoplasmosis, a disease caused by a related parasite that infects nearly one-third of all humans more than two billion people worldwide.
A team of researchers from the University of Chicago have shown that the drug, ( currently identified as JPC-2056), is extremely potent in killing Toxoplasma gondii, a parasite responsible for toxoplasmosis. The new drug appears to have little toxicity.The newly discovered drug effectively treated all types of malaria parasites, even those with multiple drug resistance mutations that make them resistant current medicines. This family of parasites, will not easily develop resistance to the new drugs according to researchers.
The toxoplasmosis parasite infects most warm-blooded animals, (even humans). The primary host is the cat family. Cats have been shown as a major reservoir of this disease. Animals become infected by eating infected meat, by contact with the feces of a cat that has itself recently been infected. Additional transmission occurs in utero from mother to fetus. During the first few weeks, the infection typically causes a mild flu like sickness that resolves in healthy people. In people with a weakened immune system,such as those infected with HIV or fetuses it can cause serious sickness or even be fatal. Toxoplasmosis may cause encephalitis, neurological diseases and chorioretinitis. It can also affect the heart and liver.
Popularity: 100% [?]
» Filed Under Toxoplasmosis
Comments
One Response to “New Anti-Malarial Medicine Treats Toxoplasmosis”
Leave a Reply
Nice article. Recommended as a refference in a research. Like IKM research. As we know that IKM is not important part in a hospital but actually IKM still a big lie with their unrealistic theory.
And this article solves the problem.
Keep the good work.
Thank you.